This advanced course develops rigorous expertise in applying state-of-the-art artificial intelligence and machine learning methodologies to high-dimensional biological and biomedical data, with a translational emphasis on cancer detection (including liquid biopsy modalities) and therapeutic discovery. Students engage in advanced computational representations of biological sequences, multi-omics data, and molecular interaction networks; design and evaluate supervised, unsupervised, and self-supervised learning frameworks; and implement deep learning architectures—including convolutional neural networks and transformer-based models—for genomics, proteomics, and structure-function prediction tasks. The course further emphasizes end-to-end ML workflows for target identification, mechanism inference, and compound prioritization, with sustained attention to reproducibility, model interpretability, uncertainty quantification, and principled decision-making in biomedical research contexts.
Course Prerequisite(s)
EN.705.601 Applied Machine Learning or EN.604.649 Principles and Methods in Machine Learning or equivalent machine learning course.
Course Offerings
|
New
Open
Artificial Intelligence in Biology – Cancer Detection & Drug Development
09/03/2026 - 12/11/2026
Thur 7:20 p.m. - 10:00 p.m. |